Mark Levine

Ascorbate recycling in human neutrophils: induction by bacteria.

New insights into the physiology and pharmacology of vitamin C.

A new recommended dietary allowance of vitamin C for healthy young women.

Cloning and functional characterization of the mouse fructose transporter, GLUT5.

Vitamin C as an antioxidant: evaluation of its role in disease prevention.

Vitamin C pharmacokinetics: implications for oral and intravenous use.

Comparison of the genomic structure and variation in the two human sodium-dependent vitamin C transporters, SLC23A1 and SLC23A2.

Pharmacologic ascorbic acid concentrations selectively kill cancer cells: action as a pro-drug to deliver hydrogen peroxide to tissues.

Intravenously administered vitamin C as cancer therapy: three cases.

Inhibition of the intestinal glucose transporter GLUT2 by flavonoids.

Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo.

Human adrenal glands secrete vitamin C in response to adrenocorticotrophic hormone.

Hypoxia-inducible factor-1alpha stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion.

Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.

Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma.

Genomic and functional analysis of the sodium-dependent vitamin C transporter SLC23A1-SVCT1.

Oxalic acid excretion after intravenous ascorbic acid administration.

Losing and finding a way at C: new promise for pharmacologic ascorbate in cancer treatment.

Major contribution of tubular secretion to creatinine clearance in mice.

Vitamin C transporter Slc23a1 links renal reabsorption, vitamin C tissue accumulation, and perinatal survival in mice.

Vitamin C: intravenous use by complementary and alternative medicine practitioners and adverse effects.

Pharmacologic ascorbate synergizes with gemcitabine in preclinical models of pancreatic cancer.

Measurement of plasma volume using fluorescent silica-based nanoparticles.

Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.

Vitamin C: a concentration-function approach yields pharmacology and therapeutic discoveries.

Vitamin C in mouse and human red blood cells: an HPLC assay.

Ascorbic acid kills Epstein-Barr virus positive Burkitt lymphoma cells and Epstein-Barr virus transformed B-cells in vitro, but not in vivo.

Parenteral ascorbate as a cancer therapeutic: a reassessment based on pharmacokinetics.

The human sodium-dependent ascorbic acid transporters SLC23A1 and SLC23A2 do not mediate ascorbic acid release in the proximal renal epithelial cell.

Antitumor effect of pharmacologic ascorbate in the B16 murine melanoma model.

Vitamin C: the known and the unknown and Goldilocks.

Low Red Blood Cell Vitamin C Concentrations Induce Red Blood Cell Fragility: A Link to Diabetes Via Glucose, Glucose Transporters, and Dehydroascorbic Acid.

Synergistic effects of ascorbate and sorafenib in hepatocellular carcinoma: New insights into ascorbate cytotoxicity.

Breaking down, starting up: can a vitamin C-enriched gelatin supplement before exercise increase collagen synthesis?

Data Triumph at C.

Measurements of red cell deformability and hydration reflect HbF and HbA2 in blood from patients with sickle cell anemia.

Chemical Transport Knockout for Oxidized Vitamin C, Dehydroascorbic Acid, Reveals Its Functions in vivo.

The SLC2A14 gene, encoding the novel glucose/dehydroascorbate transporter GLUT14, is associated with inflammatory bowel disease.

State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshop Highlights of Discussion Report.